Concepedia

Carl G. Kolvenbach

CG

15

Publications

563

Citations

13

H-Index

1988

Active since

Affiliations

Amgen (United States)(Current)

Aurora Sinai Medical Center

Carl G. Kolvenbach is an author at Amgen (United States) specializing in medicine, biochemistry, and immunology.

Top concepts

Publications per year

1988–2023

15

Publications

15

Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody C<sub>H</sub>3 domain

Arnold McAuley, Jaby Jacob, Carl G. Kolvenbach et al. · Protein Science · 2007 · 103 citations · Full text

, , +15

Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates

Heather Franey, Stephen R. Brych, Carl G. Kolvenbach et al. · Protein Science · 2010 · 82 citations · Full text

, , +22

Comparison of the biophysical characteristics of human brain-derived neurotrophic factor, neurotrophin-3, and nerve growth factor

Linda O. Narhi, Robert Rosenfeld, Jane Talvenheimo et al. · Journal of Biological Chemistry · 1993 · 67 citations · Full text

Granulocyte‐colony stimulating factor maintains a thermally stable, compact, partially folded structure at pH 2

Carl G. Kolvenbach, Linda O. Narhi, John S. Philo et al. · Journal of Peptide Research · 1997 · 40 citations

Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin

Michael J. Benecky, Carl G. Kolvenbach, David L. Amrani et al. · Biochemistry · 1988 · 39 citations

Rows per page

1–5 of 15